ENANTA PHARMACEUTICALS, INC Increase (Decrease) in Other Operating Assets
ENANTA PHARMACEUTICALS, INC (ENTA) reported Increase (Decrease) in Other Operating Assets of -$22.00 thousand for the 12-month period ending 2013-09-30, per its 10-K filed 2015-12-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2015-12-11
- ENANTA PHARMACEUTICALS, INC increase (decrease) in other operating assets for the quarter ending 2013-09-30 was $0.00.
- ENANTA PHARMACEUTICALS, INC increase (decrease) in other operating assets for fiscal 2013 was -$22.00K.
- ENANTA PHARMACEUTICALS, INC increase (decrease) in other operating assets for fiscal 2012 was -$5.00K, a 119.23% decline from fiscal 2011.
- ENANTA PHARMACEUTICALS, INC increase (decrease) in other operating assets for fiscal 2011 was $26.00K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|
| 2013-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11 | -$22.00K 10-K · filed 2015-12-11 | ||
| 2013-06-30 | -$22.00K 10-Q · filed 2014-08-12 | |||
| 2012-09-30 | -$5.00K 10-K · filed 2014-12-11 | |||
| 2012-03-31 | $32.00K 10-Q · filed 2013-05-15 | |||
| 2011-09-30 | $26.00K 10-K · filed 2013-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |